rosiglitazone has been researched along with 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2h)-pyridazinone hydrochloride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, XH; Du, D; He, L; Huang, H; Li, C; Luo, H; Qin, S; Shi, L; Wan, C; Yang, L; Ye, H; Zhang, P | 1 |
1 other study(ies) available for rosiglitazone and 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2h)-pyridazinone hydrochloride
| Article | Year |
|---|---|
DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome.
Topics: Area Under Curve; Drug Repositioning; Humans; Internet; Molecular Docking Simulation; Pharmaceutical Preparations; Protein Binding; Proteins; Pyridazines; ROC Curve; Rosiglitazone; Thiazolidinediones; User-Computer Interface | 2016 |